DNA:NYSE
Ginkgo Bioworks Holdings Inc
10,07 USD
arrow_downward
−2,00%(−0,20) 1 D
10,04 USD
arrow_downward
−0,30% (−0,030)todayFør børsåpning
Stengt: 19. okt., 16:00:03 GMT-4 · USD
search
Alle symboler
| Symbol | Pris | Endring | Endring (%) |
|---|
insights_autoGenererer viktig statistikk for DNA …
Åpne
10,38 USD
Høy
10,50 USD
Lav
9,76 USD
Markedsverdi
647,91 mill.
Snittvolum
2,94 mill.
Volum
201,00
52 u høy
18,22 USD
52 u lav
5,37 USD
EPS
−5,00 USD
Beta
1,79
Utestående aksjer
55,38 mill.
Antall ansatte
485
Åpne
10,38 USD
Høy
10,50 USD
Lav
9,76 USD
Markedsverdi
647,91 mill.
Snittvolum
2,94 mill.
Volum
201,00
52 u høy
18,22 USD
52 u lav
5,37 USD
EPS
−5,00 USD
Beta
1,79
Utestående aksjer
55,38 mill.
Antall ansatte
485
Nyhetssaker
Fra nettkilder og nyhetspartnere
Investing.com Canada
·
for 12 timer siden
Form 144 Ginkgo Bioworks Holdings For: 19 October By Investing.com
Stock Titan
·
for 12 timer siden
A 766-share sale proposed by Ginkgo Bioworks (DNA) officer Steve Coen includes shares to cover taxes.
https://www.dars.gov.et/
·
for 1 uke siden
DNA Q2 2026 Earnings: Narrower-Than-Expected Loss Beats Consensus, but Shares Slide 7.57% - Weak Earnings Momentum
Profil
Ginkgo Bioworks Holdings, Inc. is an American biotech company founded in 2008 by five scientists from MIT. The company specializes in using genetic engineering to produce bacteria with industrial applications for other biotech companies, saving other companies the cost of reproducing the initial stages of design in synthetic biology. The self-proclaimed "Organism Company" was one of the world's largest privately held biotech companies, valued at $4.2 billion in 2019. It raised $290 million in September and $350 million in October of that year. Ginkgo Bioworks went public on the New York Stock Exchange via a SPAC merger on September 17, 2021. Wikipedia
Om Ginkgo Bioworks Holdings Inc
Administrerende direktørJason Kelly
Ansatte485
Grunnlagt2008
HovedkontorBoston, Massachusetts, USA
Sektor-
Nettstedginkgo.bio